Announce Date | 05/20/2025 |
EPS Normalized Actual | $2.43 (Miss by $-0.02) |
EPS GAAP Actual | $2.43 (Miss by $-0.02) |
Revenue Actual | $0.686471B |
Revenue Surprise | Beat by $686.471M |
Announce Date | 07/30/2025 (Pre-Market) |
EPS Normalized Estimate | $3.51 |
EPS GAAP Estimate | $3.51 |
Revenue Estimate | $0.8011992B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Oct 2023 | INF | 0 | 0 | 0 | |
Oct 2022 | INF | 0 | 0 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Apr 2025) | 2.64 | 0.19 | 0.686471B | -3.19% | -46.73M |
FQ1 2025 (Jan 2025) | 4.33 | 1.62 | 0.673623B | 11.79% | -32.18M |
FQ4 2024 (Oct 2024) | 14.54 | 14.54 | 0.979638B | 9.45% | 979.64M |
FQ3 2024 (Jul 2024) | 11.26 | 11.26 | 0.722704B | 10.07% | 722.7M |
FQ2 2024 (Apr 2024) | 7.87 | 7.87 | 0.70838B | 100% | 708.38M |
FQ1 2024 (Jan 2024) | 3.06 | 3.06 | 0.594196B | 13.27% | 594.2M |
FQ4 2023 (Oct 2023) | 13.98 | 6.62 | 0.887032B | 0.03% | 101.93M |
FQ3 2023 (Jul 2023) | 0 | 0.16 | 0.649957B | -18.1% | 119.76M |
FQ4 Announce Date
07/30/2025 (Pre-Market)
Consensus EPS Estimates
3.51
Consensus Revenue Estimates
0.8011992B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 11.713 | -- | 11.713 | 11.713 | 1 |
FQ3 2026 (Jul 2026) | 9.5287 | -- | 9.5287 | 9.5287 | 1 |
FQ2 2026 (Apr 2026) | 7.8291 | 66.28 | 7.8291 | 7.8291 | 1 |
FQ1 2026 (Jan 2026) | 4.1935 | -3.26 | 4.1935 | 4.1935 | 1 |
FQ4 2025 (Oct 2025) | 2.57 | -465.76 | 2.57 | 2.57 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 0.88B | -- | 0.88B | 0.88B | 1 |
FQ3 2026 (Jul 2026) | 0.84B | -- | 0.84B | 0.84B | 1 |
FQ2 2026 (Apr 2026) | 0.73B | 5.6 | 0.73B | 0.73B | 1 |
FQ1 2026 (Jan 2026) | 0.59B | -13.65 | 0.59B | 0.59B | 1 |
FQ4 2025 (Oct 2025) | 0.8B | -21.91 | 0.8B | 0.8B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Apr 2025) | 2.45 | 2.64 | 0.19 | 7.2% |
FQ1 2025 (Jan 2025) | 2.71 | 4.33 | 1.62 | 37.41% |
FQ4 2024 (Oct 2024) | 14.54 | 14.54 | 100% | |
FQ3 2024 (Jul 2024) | 11.26 | 11.26 | 100% | |
FQ2 2024 (Apr 2024) | 7.87 | 7.87 | 100% | |
FQ1 2024 (Jan 2024) | 3.06 | 3.06 | 100% | |
FQ4 2023 (Oct 2023) | 7.36 | 13.98 | 6.62 | 47.35% |
FQ3 2023 (Jul 2023) | -0.16 | 0 | 0.16 | INF% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Apr 2025) | $0.73B | $0.69B | $-46.73M | -6.81% |
FQ1 2025 (Jan 2025) | $0.71B | $0.67B | $-32.18M | -4.78% |
FQ4 2024 (Oct 2024) | $0B | $0.98B | $979.64M | 100% |
FQ3 2024 (Jul 2024) | $0B | $0.72B | $722.7M | 100% |
FQ2 2024 (Apr 2024) | $0B | $0.71B | $708.38M | 100% |
FQ1 2024 (Jan 2024) | $0B | $0.59B | $594.2M | 100% |
FQ4 2023 (Oct 2023) | $0.79B | $0.89B | $101.93M | 11.49% |
FQ3 2023 (Jul 2023) | $0.53B | $0.65B | $119.76M | 18.43% |